Patent · US Expired

Somatostatin-dopamine chimeric analogs

US7572883B2 · kind B2 · utility

17Cited by

18References

8Claims

0Family size

Assignee

Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S) SAS · FR

Inventors

Michael DeWitt Culler · Gretna, US
Zheng Xin Dong · Holliston, US
Sun H. Kim · Needham, US
Jacques-Pierre Moreau · Upton, US

Key dates

Filing date	May 15, 2006
Grant date	Aug 11, 2009
Priority date	—
Expiry date	May 15, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a series of somatostatin-dopamine chimeric analogs which retain both somatostatin and dopamine activity in vivo. An example is:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.